Blockade of Base Excision Repair: Inhibition of Small Lesions Results in Big Consequences to Cancer Cells

DNA Repair in Cancer Therapy

Volumn , Issue , 2012, Pages 29-53

  Vascotto, Carlo ^a   Fishel, Melissa L ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882388730     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384999-1.10003-4     Document Type: Chapter

References (273)

1. Izumi T., et al. Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage. Toxicology 2003, 193(1-2):43-65.
2. Plummer R. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target. Clin Cancer Res 2010, 16(18):4527-4531.
3. Kelley M.R., Fishel M.L. DNA repair proteins as molecular targets for cancer therapeutics. Anticancer Agents Med Chem 2008, 8(4):417-425.
4. Lodish H., et al. Molecular biology of the cell 2004, WH Freeman, New York, NY. 5th ed.
5. Sung J.S., Demple B. Roles of base excision repair subpathways in correcting oxidized abasic sites in DNA. FEBS J 2006, 273(8):1620-1629.
6. Friedberg E.C., McDaniel L.D., Schultz R.A. The role of endogenous and exogenous DNA damage and mutagenesis. Curr Opin Genet Dev 2004, 14(1):5-10.
7. Dianov G.L., Allinson S.L. DNA base damage recognition and processing. Genome Dyn Stab 2007, 1:287-314.
8. Dawson T.L., et al. Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am J Physiol 1993, 264(4 Pt 1):C961-C967.
9. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000, 86(5):494-501.
10. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995, 64:97-112.
11. Scandalios J.G. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 2005, 38(7):995-1014.
12. Kasai H., et al. 8-Hydroxyguanine, a DNA adduct formed by oxygen radicals: its implication on oxygen radical-involved mutagenesis/carcinogenesis. J Toxicol Sci 1991, 16(Suppl 1):95-105.
13. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993, 362(6422):709-715.
14. Dalhus B., et al. DNA base repair - recognition and initiation of catalysis. FEMS Microbiol Rev 2009, 33(6):1044-1078.
15. Kow Y.W. Repair of deaminated bases in DNA. Free Radic Biol Med 2002, 33(7):886-893.
16. Kreutzer D.A., Essigmann J.M. Oxidized, deaminated cytosines are a source of C /> T transitions in vivo. Proc Natl Acad Sci, USA 1998, 95(7):3578-3582.
17. Dizdaroglu M., Bergtold D.S. Characterization of free radical-induced base damage in DNA at biologically relevant levels. Anal Biochem 1986, 156(1):182-188.
18. Purmal A.A., Kow Y.W., Wallace S.S. 5-Hydroxypyrimidine deoxynucleoside triphosphates are more efficiently incorporated into DNA by exonuclease-free Klenow fragment than 8-oxopurine deoxynucleoside triphosphates. Nucleic Acids Res 1994, 22(19):3930-3935.
19. Zuo S., Boorstein R.J., Teebor G.W. Oxidative damage to 5-methylcytosine in DNA. Nucleic Acids Res 1995, 23(16):3239-3243.
20. Beranek D.T. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res 1990, 231(1):11-30.
21. Tell G., Wilson D.M. Targeting DNA repair proteins for cancer treatment. Cell Mol Life Sci 2010, 67(21):3569-3572.
22. Colvin D. Alkylating agents and platinum antitumor compounds. Cancer Medicine 1997, 949-975. Williams & Wilkins, Baltimore, MD. 4th ed. J.F. Holland, E. Frei, R.C. Bast (Eds.).
23. Sedgwick B. Repairing DNA-methylation damage. Nat Rev Mol Cell Biol 2004, 5(2):148-157.
24. Fang Q., et al. Repair of O4-alkylthymine by O6-alkylguanine-DNA alkyltransferases. J Biol Chem 2010, 285(11):8185-8195.
25. Huffman J.L., Sundheim O., Tainer J.A. DNA base damage recognition and removal: new twists and grooves. Mutat Res 2005, 577(1-2):55-76.
26. Daniels D.S., Tainer J.A. Conserved structural motifs governing the stoichiometric repair of alkylated DNA by O(6)-alkylguanine-DNA alkyltransferase. Mutat Res 2000, 460(3-4):151-163.
27. Watson J, et al., The mutability and repair of DNA. In: Watson, JD, Baker TA, Bell SP, Gann A, Levine M, Losick R, editors. Molecular biology of the gene, 5th ed. Cold Spring Harbor, NY: CSHL Press, in conjunction with Benjamin Cummings. p. 235-58.
28. Iyer R.R., et al. DNA mismatch repair: functions and mechanisms. Chem Rev 2006, 106(2):302-323.
29. Mellon I. Transcription-coupled repair: a complex affair. Mutat Res 2005, 577(1-2):155-161.
30. Mitra S., et al. Complexities of DNA base excision repair in mammalian cells. Mol Cells 1997, 7(3):305-312.
31. Robertson A.B., et al. DNA repair in mammalian cells: Base excision repair: the long and short of it. Cell Mol Life Sci 2009, 66(6):981-993.
32. Frosina G., et al. Two pathways for base excision repair in mammalian cells. J Biol Chem 1996, 271(16):9573-9578.
33. Lindahl T. An N-glycosidase from Escherichia coli that releases free uracil from DNA containing deaminated cytosine residues. Proc Natl Acad Sci, USA 1974, 71(9):3649-3653.
34. Dodson M.L., Michaels M.L., Lloyd R.S. Unified catalytic mechanism for DNA glycosylases. J Biol Chem 1994, 269(52):32709-32712.
35. Fromme J.C., Banerjee A., Verdine G.L. DNA glycosylase recognition and catalysis. Curr Opin Struct Biol 2004, 14(1):43-49.
36. Kavli B., et al. Excision of cytosine and thymine from DNA by mutants of human uracil-DNA glycosylase. EMBO J 1996, 15(13):3442-3447.
37. Daniels D.S., et al. DNA binding and nucleotide flipping by the human DNA repair protein AGT. Nat Struct Mol Biol 2004, 11(8):714-720.
38. Hollis T., Ichikawa Y., Ellenberger T. DNA bending and a flip-out mechanism for base excision by the helix-hairpin-helix DNA glycosylase, Escherichia coli AlkA. EMBO J 2000, 19(4):758-766.
39. Bruner S.D., et al. Structural and mechanistic studies on repair of 8-oxoguanine in mammalian cells. Cold Spring Harb Symp Quant Biol 2000, 65:103-111.
40. Barrett T.E., et al. Crystal structure of a G: T/U mismatch-specific DNA glycosylase: mismatch recognition by complementary-strand interactions. Cell 1998, 92(1):117-129.
41. Parikh S.S., et al. Base excision repair initiation revealed by crystal structures and binding kinetics of human uracil-DNA glycosylase with DNA. EMBO J 1998, 17(17):5214-5226.
42. Mol C.D., et al. DNA-bound structures and mutants reveal abasic DNA binding by APE1 and DNA repair coordination [corrected]. Nature 2000, 403(6768):451-456.
43. Hosfield D.J., et al. Structure of the DNA repair enzyme endonuclease IV and its DNA complex: double-nucleotide flipping at abasic sites and three-metal-ion catalysis. Cell 1999, 98(3):397-408.
44. Parikh S.S., et al. Base excision repair initiation revealed by crystal structures and binding kinetics of human uracil-DNA glycosylase with DNA. EMBO J 1998, 17(17):5214-5226.
45. Lindahl T., et al. DNA N-glycosidases: properties of uracil-DNA glycosidase from. Escherichia coli. J Biol Chem 1977, 252(10):3286-3294.
46. Masaoka A., et al. Mammalian 5-formyluracil-DNA glycosylase. 2. Role of SMUG1 uracil-DNA glycosylase in repair of 5-formyluracil and other oxidized and deaminated base lesions. Biochemistry 2003, 42(17):5003-5012.
47. Wibley J.E., et al. Structure and specificity of the vertebrate anti-mutator uracil-DNA glycosylase SMUG1. Mol Cell 2003, 11(6):1647-1659.
48. Thayer M.M., et al. Novel DNA binding motifs in the DNA repair enzyme endonuclease III crystal structure. EMBO J 1995, 14(16):4108-4120.
49. Fromme J.C., et al. Structural basis for removal of adenine mispaired with 8-oxoguanine by MutY adenine DNA glycosylase. Nature 2004, 427(6975):652-656.
50. Michaels M.L., et al. A repair system for 8-oxo-7,8-dihydrodeoxyguanine. Biochemistry 1992, 31(45):10964-10968.
51. Klungland A., et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci, USA 1999, 96(23):13300-13305.
52. Yang H., et al. Enhanced activity of adenine-DNA glycosylase (Myh) by apurinic/apyrimidinic endonuclease (Ape1) in mammalian base excision repair of an A/GO mismatch. Nucleic Acids Res 2001, 29(3):743-752.
53. Elder R.H., Dianov G.L. Repair of dihydrouracil supported by base excision repair in mNTH1 knock-out cell extracts. J Biol Chem 2002, 277(52):50487-50490.
54. Fromme J.C., Verdine G.L. Structural insights into lesion recognition and repair by the bacterial 8-oxoguanine DNA glycosylase. MutM Nat Struct Biol 2002, 9(7):544-552.
55. Dou H., Mitra S., Hazra T.K. Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2. J Biol Chem 2003, 278(50):49679-49684.
56. Wiederhold L., et al. AP endonuclease-independent DNA base excision repair in human cells. Mol Cell 2004, 15(2):209-220.
57. Takao M., et al. Human Nei-like protein NEIL3 has AP lyase activity specific for single-stranded DNA and confers oxidative stress resistance in Escherichia coli mutant. Genes Cells 2009, 14(2):261-270.
58. Abner C.W., et al. Base excision and DNA binding activities of human alkyladenine DNA glycosylase are sensitive to the base paired with a lesion. J Biol Chem 2001, 276(16):13379-13387.
59. Chakravarti D., et al. Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase. J Biol Chem 1991, 266(24):15710-15715.
60. Berdal K.G., Johansen R.F., Seeberg E. Release of normal bases from intact DNA by a native DNA repair enzyme. EMBO J 1998, 17(2):363-367.
61. Lau A.Y., et al. Crystal structure of a human alkylbase-DNA repair enzyme complexed to DNA: mechanisms for nucleotide flipping and base excision. Cell 1998, 95(2):249-258.
62. Guillet M., Boiteux S. Endogenous DNA abasic sites cause cell death in the absence of Apn1, Apn2 and Rad1/Rad10 in Saccharomyces cerevisiae. EMBO J 2002, 21(11):2833-2841.
63. Demple B., Herman T., Chen D.S. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Natl Acad Sci, USA 1991, 88(24):11450-11454.
64. Xanthoudakis S., et al. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc Natl Acad Sci USA 1996, 93(17):8919-8923.
65. Vascotto C., et al. Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 2009, 9(4):1058-1074.
66. Jiang Y., et al. Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression. Cancer Investigation 2010, 28(9):885-895.
67. Fishel M.L., et al. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst) 2008, 7(2):177-186.
68. Myles G.M., Sancar A. DNA repair. Chem Res Toxicol 1989, 2(4):197-226.
69. Klungland A., Lindahl T. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J 1997, 16(11):3341-3348.
70. Matsumoto Y., Kim K. Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 1995, 269(5224):699-702.
71. Srivastava D.K., et al. Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps. J Biol Chem 1998, 273(33):21203-21209.
72. Evans A.R., Limp-Foster M., Kelley M.R. Going APE over ref-1. Mutat Res 2000, 461(2):83-108.
73. Wilson D.M., Barsky D. The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat Res 2001, 485(4):283-307.
74. Yang N., Chaudhry M.A., Wallace S.S. Base excision repair by hNTH1 and hOGG1: a two edged sword in the processing of DNA damage in gamma-irradiated human cells. DNA Repair (Amst) 2006, 5(1):43-51.
75. Kuninger D.T., et al. Human AP-endonuclease 1 and hnRNP-L interact with a nCaRE-like repressor element in the AP-endonuclease 1 promoter. Nucleic Acids Res 2002, 30(3):823-829.
76. Vascotto C., et al. APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process. Mol Cell Biol 2009, 29(7):1834-1854.
77. Wong D., Demple B. Modulation of the 5'-deoxyribose-5-phosphate lyase and DNA synthesis activities of mammalian DNA polymerase beta by apurinic/apyrimidinic endonuclease 1. J Biol Chem 2004, 279(24):25268-25275.
78. Burgers M., et al. Eukaryotic DNA polymerases: proposal for a revised nomenclature. J Biol Chem 2001, 276(47):43487-43490.
79. Kumar A., et al. Studies of the domain structure of mammalian DNA polymerase beta. Identification of a discrete template binding domain. J Biol Chem 1990, 265(4):2124-2131.
80. Bennett S.E., Sung J.S., Mosbaugh D.W. Fidelity of uracil-initiated base excision DNA repair in DNA polymerase beta-proficient and -deficient mouse embryonic fibroblast cell extracts. J Biol Chem 2001, 276(45):42588-42600.
81. Zhang Q.M., Dianov G.L. DNA repair fidelity of base excision repair pathways in human cell extracts. DNA Repair (Amst) 2005, 4(2):263-270.
82. Gu H., et al. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994, 265(5168):103-106.
83. Hirose F., et al. Difference in the expression level of DNA polymerase beta among mouse tissues: high expression in the pachytene spermatocyte. Exp Cell Res 1989, 181(1):169-180.
84. Zmudzka B.Z., et al. Characterization of DNA polymerase beta mRNA: cell-cycle and growth response in cultured human cells. Nucleic Acids Res 1988, 16(20):9587-9596.
85. Fornace A.J., et al. Induction of beta-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells. Mol Cell Biol 1989, 9(2):851-853.
86. Cabelof D.C., et al. Induction of DNA polymerase beta-dependent base excision repair in response to oxidative stress in vivo. Carcinogenesis 2002, 23(9):1419-1425.
87. Chan K.K., Zhang Q.M., Dianov G.L. Base excision repair fidelity in normal and cancer cells. Mutagenesis 2006, 21(3):173-178.
88. Chan K., et al. Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repair. Mutagenesis 2007, 22(3):183-188.
89. Tomkinson A.E., et al. DNA ligases: structure, reaction mechanism, and function. Chem Rev 2006, 106(2):687-699.
90. Tomkinson A.E., Levin D.S. Mammalian DNA ligases. Bioessays 1997, 19(10):893-901.
91. Levin D.S., et al. An interaction between DNA ligase I and proliferating cell nuclear antigen: implications for Okazaki fragment synthesis and joining. Proc Natl Acad Sci, USA 1997, 94(24):12863-12868.
92. Soderhall S. DNA ligases during rat liver regeneration. Nature 1976, 260(5552):640-642.
93. Aboussekhra A., et al. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 1995, 80(6):859-868.
94. Levin D.S., et al. Interaction between PCNA and DNA ligase I is critical for joining of Okazaki fragments and long-patch base-excision repair. Current Biology 2000, 10(15):919-922. S1-S2.
95. Barnes D.E., et al. Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell 1992, 69(3):495-503.
96. Prigent C., et al. Aberrant DNA repair and DNA replication due to an inherited enzymatic defect in human DNA ligase I. Mol Cell Biol 1994, 14(1):310-317.
97. Mackey Z.B., et al. An alternative splicing event which occurs in mouse pachytene spermatocytes generates a form of DNA ligase III with distinct biochemical properties that may function in meiotic recombination. Mol Cell Biol 1997, 17(2):989-998.
98. Tomkinson A.E., Mackey Z.B. Structure and function of mammalian DNA ligases. Mutat Res 1998, 407(1):1-9.
99. Tomkinson A.E., et al. Completion of base excision repair by mammalian DNA ligases. Prog Nucleic Acid Res Mol Biol 2001, 68:151-164.
100. Taylor R.M., et al. Role of the DNA ligase III zinc finger in polynucleotide binding and ligation. Nucleic Acids Res 1998, 26(21):4804-4810.
101. Caldecott K.W., et al. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol 1994, 14(1):68-76.
102. Caldecott K.W., et al. Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells. Nucleic Acids Res 1995, 23(23):4836-4843.
103. Cappelli E., et al. Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J Biol Chem 1997, 272(38):23970-23975.
104. Thompson L.H., West M.G. XRCC1 keeps DNA from getting stranded. Mutat Res 2000, 459(1):1-18.
105. Tebbs R.S., et al. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev Biol 1999, 208(2):513-529.
106. Nash R.A., et al. XRCC1 protein interacts with one of two distinct forms of DNA ligase III. Biochemistry 1997, 36(17):5207-5211.
107. Kubota Y., et al. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 1996, 15(23):6662-6670.
108. Masson M., et al. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 1998, 18(6):3563-3571.
109. Vidal A.E., et al. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 2001, 20(22):6530-6539.
110. Marsin S., et al. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J Biol Chem 2003, 278(45):44068-44074.
111. Fan J., et al. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res 2004, 32(7):2193-2201.
112. Wong H.K., Wilson D.M. XRCC1 and DNA polymerase beta interaction contributes to cellular alkylating-agent resistance and single-strand break repair. J Cell Biochem 2005, 95(4):794-804.
113. Hassa O., Hottiger M.O. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 2008, 13:3046-3082.
114. Zharkov D. Base excision DNA repair. Cellular and Molecular Life Sciences 2008, 65(10):1544-1565.
115. Allinson S.L., Dianova, Dianov G.L. Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing. Acta Biochim Pol 2003, 50(1):169-179.
116. Rouleau M., Aubin R.A., Poirier G.G. Poly(ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci 2004, 117(Pt 6):815-825.
117. Hassa O., et al. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?. Microbiol Mol Biol Rev 2006, 70(3):789-829.
118. Parsons J.L., et al. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts. FEBS J 2005, 272(8):2012-2021.
119. Maga G., Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 2003, 116(Pt 15):3051-3060.
120. Prakash S., Johnson R.E., Prakash L. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu Rev Biochem 2005, 74:317-353.
121. Ko R., Bennett S.E. Physical and functional interaction of human nuclear uracil-DNA glycosylase with proliferating cell nuclear antigen. DNA Repair (Amst) 2005, 4(12):1421-1431.
122. Oyama M., et al. Human NTH1 physically interacts with p53 and proliferating cell nuclear antigen. Biochem Biophys Res Commun 2004, 321(1):183-191.
123. Friedrich-Heineken E., et al. The two DNA clamps Rad9/Rad1/Hus1 complex and proliferating cell nuclear antigen differentially regulate flap endonuclease 1 activity. J Mol Biol 2005, 353(5):980-989.
124. Fan J., Wilson D.W. Protein-protein interactions and posttranslational modifications in mammalian base excision repair. Free Radic Biol Med 2005, 38(9):1121-1138.
125. Almeida K.H., Sobol R.W. A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst) 2007, 6(6):695-711.
126. Parrilla-Castellar E.R., Arlander S.J., Karnitz L. Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair (Amst) 2004, 3(8-9):1009-1014.
127. Shi Z., et al. S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine. Cancer Res 2001, 61(3):1065-1072.
128. Guan X., et al. The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates NEIL1 glycosylase. Nucleic Acids Res 2007, 35(8):2463-2472.
129. Guan X., et al. The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates DNA repair enzyme TDG glycosylase. Nucleic Acids Res 2007, 35(18):6207-6218.
130. Gembka A., et al. The checkpoint clamp, Rad9-Rad1-Hus1 complex, preferentially stimulates the activity of apurinic/apyrimidinic endonuclease 1 and DNA polymerase beta in long patch base excision repair. Nucleic Acids Res 2007, 35(8):2596-2608.
131. Toueille M., et al. The human Rad9/Rad1/Hus1 damage sensor clamp interacts with DNA polymerase beta and increases its DNA substrate utilisation efficiency: implications for DNA repair. Nucleic Acids Res 2004, 32(11):3316-3324.
132. Wang W., et al. The human Rad9-Rad1-Hus1 checkpoint complex stimulates flap endonuclease 1. Proc Natl Acad Sci, USA 2004, 101(48):16762-16767.
133. Smirnova E., et al. The human checkpoint sensor and alternative DNA clamp Rad9-Rad1-Hus1 modulates the activity of DNA ligase I, a component of the long-patch base excision repair machinery. Biochem J 2005, 389(Pt 1):13-17.
134. Xanthoudakis S., Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 1992, 11(2):653-665.
135. Harrison L., et al. Human apurinic endonuclease gene (APE): structure and genomic mapping (chromosome 14q11.2-12). Hum Mol Genet 1992, 1(9):677-680.
136. Akiyama K., et al. Structure, promoter analysis and chromosomal assignment of the human APEX gene. Biochim Biophys Acta 1994, 1219(1):15-25.
137. Yu E., Gaucher S., Hadi M.Z. Probing conformational changes in Ape1 during the progression of base excision repair. Biochemistry 2010, 49(18):3786-3796.
138. Tell G., et al. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?. Antioxid Redox Signal 2005, 7(3-4):367-384.
139. Moran L.K., Gutteridge J.M., Quinlan G.J. Thiols in cellular redox signalling and control. Curr Med Chem 2001, 8(7):763-772.
140. Gaiddon C., Moorthy N.C., Prives C. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J 1999, 18(20):5609-5621.
141. Xanthoudakis S., et al. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 1992, 11(9):3323-3335.
142. Nishi T., et al. Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J Biol Chem 2002, 277(46):44548-44556.
143. Huang R., Adamson E.D. Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism. DNA Cell Biol 1993, 12(3):265-273.
144. Tell G., et al. Ref-1 controls pax-8 DNA-binding activity. Biochem Biophys Res Commun 1998, 252(1):178-183.
145. Walker L.J., et al. Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding. Mol Cell Biol 1993, 13(9):5370-5376.
146. Walker L.J., et al. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res 1994, 22(23):4884-4889.
147. Georgiadis M.M., et al. Evolution of the redox function in mammalian apurinic/apyrimidinic endonuclease. Mutat Res 2008, 643(1-2):54-63.
148. Jayaraman L., et al. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 1997, 11(5):558-570.
149. Ordway J.M., Eberhart D., Curran T. Cysteine 64 of Ref-1 is not essential for redox regulation of AP-1 DNA binding. Mol Cell Biol 2003, 23(12):4257-4266.
150. Ando K., et al. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 2008, 36(13):4327-4336.
151. Tell G., Fantini D., Quadrifoglio F. Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment. Cell Mol Life Sci 2010, 67(21):3589-3608.
152. Okazaki T., et al. A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J Biol Chem 1994, 269(45):27855-27862.
153. Mallette L.E. Regulation of blood calcium in humans. Endocrinol Metab Clin North Am 1989, 18(3):601-610.
154. Izumi T., Henner W.D., Mitra S. Negative regulation of the major human AP-endonuclease, a multifunctional protein. Biochemistry 1996, 35(47):14679-14683.
155. Bhakat K.K., et al. Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. EMBO J 2003, 22(23):6299-6309.
156. Barzilay G., et al. Site-directed mutagenesis of the human DNA repair enzyme HAP1: identification of residues important for AP endonuclease and RNase H activity. Nucleic Acids Res 1995, 23(9):1544-1550.
157. Chattopadhyay R., et al. Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. Mol Cell Biol 2008, 28(23):7066-7080.
158. Marenstein D.R., Wilson D.M., Teebor G.W. Human AP endonuclease (APE1) demonstrates endonucleolytic activity against AP sites in single-stranded DNA. DNA Repair (Amst) 2004, 3(5):527-533.
159. Berquist B.R., McNeill D.R., Wilson D.M. Characterization of abasic endonuclease activity of human Ape1 on alternative substrates, as well as effects of ATP and sequence context on AP site incision. J Mol Biol 2008, 379(1):17-27.
160. Tanaka M., Chock B., Stadtman E.R. Oxidized messenger RNA induces translation errors. Proc Natl Acad Sci, USA 2007, 104(1):66-71.
161. Moreira I., et al. Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med 2008, 44(8):1493-1505.
162. Asai T., et al. Increase in Ref-1 mRNA and protein by thyrotropin in rat thyroid FRTL-5 cells. Biochem Biophys Res Commun 1997, 236(1):71-74.
163. Tell G., et al. TSH controls Ref-1 nuclear translocation in thyroid cells. J Mol Endocrinol 2000, 24(3):383-390.
164. Ramana C.V., et al. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci, USA 1998, 95(9):5061-5066.
165. Tell G., et al. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009, 11(3):601-620.
166. Busso C.S., Lake M.W., Izumi T. Posttranslational modification of mammalian AP endonuclease (APE1). Cell Mol Life Sci 2010, 67(21):3609-3620.
167. Fantini D., et al. Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions. Nucleic Acids Res 2010, 38(22):8239-8256.
168. Yacoub A., Kelley M.R., Deutsch W.A. The DNA repair activity of human redox/repair protein APE/Ref-1 is inactivated by phosphorylation. Cancer Res 1997, 57(24):5457-5459.
169. Fritz G., Kaina B. Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1. Oncogene 1999, 18(4):1033-1040.
170. Huang E., et al. The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death. Nat Cell Biol 2010, 12(6):563-571.
171. Nakayama K.I., Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006, 6(5):369-381.
172. Chau V., et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989, 243(4898):1576-1583.
173. Nijman S.M., et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 123(5):773-786.
174. Busso C.S., Iwakuma T., Izumi T. Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway. Oncogene 2009, 28(13):1616-1625.
175. Qu J., et al. Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of cysteines 93 and 310. Nucleic Acids Res 2007, 35(8):2522-2532.
176. Fan Z., et al. Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat Immunol 2003, 4(2):145-153.
177. Chattopadhyay R., et al. Identification and characterization of mitochondrial abasic (AP)-endonuclease in mammalian cells. Nucleic Acids Res 2006, 34(7):2067-2076.
178. Li M., et al. Identification and characterization of mitochondrial targeting sequence of human apurinic/apyrimidinic endonuclease 1. J Biol Chem 2010, 285(20):14871-14881.
179. Meynard D., et al. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity. Oncol Rep 2007, 17(5):1213-1221.
180. Jiang Y., et al. Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res 2008, 68(15):6425-6434.
181. Minotti G., et al. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004, 56(2):185-229.
182. Fawcett H., et al. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells. Int J Oncol 2005, 27(6):1717-1726.
183. Alexandre J., et al. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 2007, 67(8):3512-3517.
184. Burdak-Rothkamm S., Prise K.M. New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells. Eur J Pharmacol 2009, 625(1-3):151-155.
185. Astsaturov I., et al. Synthetic lethal screen of an EGFR-centered network to improve targeted therapies. Sci Signal 2010, 3(140):ra60.
186. Moeller B.J., Pasqualini R., Arap W. Targeting cancer-specific synthetic lethality in double-strand DNA break repair. Cell Cycle 2009, 8(12):1872-1876.
187. Carden C., Yap T.A., Kaye S.B. PARP inhibition: targeting the Achilles' heel of DNA repair to treat germline and sporadic ovarian cancers. Curr Opin Oncol 2010, 22(5):473-480.
188. Darzynkiewicz Z., Traganos F., Wlodkowic D. Impaired DNA damage response - an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy. Eur J Pharmacol 2009, 625(1-3):143-150.
189. Panda H., et al. Amino acid Asp181 of 5'-flap endonuclease 1 is a useful target for chemotherapeutic development. Biochemistry 2009, 48(42):9952-9958.
190. Gao Z., et al. Inhibitors of DNA polymerase beta: activity and mechanism. Bioorg Med Chem 2008, 16(8):4331-4340.
191. Barakat K., Tuszynski J. Relaxed complex scheme suggests novel inhibitors for the lyase activity of DNA polymerase beta. J Mol Graph Model 2011, 29:702-715.
192. Hu H.Y., et al. Identification of small molecule synthetic inhibitors of DNA polymerase beta by NMR chemical shift mapping. J Biol Chem 2004, 279(38):39736-39744.
193. Martin S.A., et al. DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1. Cancer Cell 2010, 17(3):235-248.
194. Larsen E., et al. Organ and cell specificity of base excision repair mutants in mice. Mutat Res 2007, 614(1-2):56-68.
195. Fishel M.L., Kelley M.R. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 2007, 28(3-4):375-395.
196. Abbotts R., Madhusudan S. Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer. Cancer Treat Rev 2010, 36(5):425-435.
197. Ono Y., et al. Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease. Mutat Res 1994, 315(1):55-63.
198. Bobola M.S., et al. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin Cancer Res 2005, 11(20):7405-7414.
199. Yang Z.Z., Chen X.H., Wang D. Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector. Clin Lymphoma Myeloma 2007, 7(4):296-304.
200. Zhang Y., et al. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Int J Oncol 2009, 35(5):1069-1079.
201. Lau J., et al. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br J Cancer 2004, 91(6):1166-1173.
202. Koukourakis M.I., et al. Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. Int J Radiat Oncol Biol Phys 2001, 50(1):27-36.
203. Kakolyris S., et al. Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease. Histopathology 1998, 33(6):561-569.
204. Bobola M.S., et al. Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas. Clin Cancer Res 2001, 7(11):3510-3518.
205. Simeonov A., et al. Identification and characterization of inhibitors of human apurinic/apyrimidinic endonuclease APE1. PLoS ONE 2009, 4(6). e5740.
206. Luo M., et al. Redox regulation of DNA repair: Implications for human health and cancer therapeutic development. Antioxid Redox Signal 2010, 12(11):1247-1269.
207. Bapat A., Fishel M., Kelley M.R. Going ape as an approach to cancer therapeutics. Antioxid Redox Signal 2009, 11:651-668.
208. Luo M., et al. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal 2008, 10(11):1853-1867.
209. Madhusudan S., Middleton M.R. The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer. Cancer Treat Rev 2005, 31(8):603-617.
210. Madhusudan S., Hickson I.D. DNA repair inhibition: a selective tumour targeting strategy. Trends Mol Med 2005, 11(11):503-511.
211. Kelley M.R., Georgiadis M.M., Fishel M.L. The tumor microenvironment 2010, 133-168. Springer Science+Business Media, Framingham, MA.
212. Zou G.M., et al. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol 2009, 219(1):209-218.
213. Pietras K., Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 2010, 316(8):1324-1331.
214. Zou G.M., Maitra A. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Mol Cancer Ther 2008, 7(7):2012-2021.
215. Rosa S., et al. Processing in vitro of an abasic site reacted with methoxyamine: a new assay for the detection of abasic sites formed in vivo. Nucleic Acids Res 1991, 19(20):5569-5574.
216. Liuzzi M., Talpaert-Borle M. A new approach to the study of the base-excision repair pathway using methoxyamine. J Biol Chem 1985, 260(9):5252-5258.
217. Horton J.K., et al. Protection against methylation-induced cytotoxicity by DNA polymerase beta-dependent long patch base excision repair. J Biol Chem 2000, 275(3):2211-2218.
218. Liu L., Nakatsuru Y., Gerson S.L. Base excision repair as a therapeutic target in colon cancer. Clin Cancer Res 2002, 8(9):2985-2991.
219. Fishel M.L., et al. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. Clin Cancer Res 2007, 13(1):260-267.
220. Rinne M., Caldwell D., Kelley M.R. Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. Mol Cancer Ther 2004, 3(8):955-967.
221. Taverna P., et al. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization. Cancer Res 2003, 63(4):838-846.
222. Liu L., et al. Prevention of base excision repair by TRC102 (methoxyamine) potentiates the anti-tumor activity of pemetrexed in vitro and in vivo. ASCO Annual Meeting abstract 2007, 25(18S):13005.
223. Anthony S., et al. A phase I study of daily oral TRC102 (methoxyamine) to enhance the therapeutic effects of pemetrexed in patients with advanced refractory cancer. J Clin Oncol (Meeting Abstracts) 2009, 27(15S):2552.
224. Madhusudan S., et al. Isolation of a small molecule inhibitor of DNA base excision repair. Nucleic Acids Res 2005, 33(15):4711-4724.
225. Bapat A., et al. Novel small molecule inhibitor of Ape1 endonuclease blocks proliferation and reduces viability of glioblastoma cells. J Pharmacol Exp Ther 2010, 334(3):988-998.
226. Zawahir Z., et al. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors. J Med Chem 2009, 52(1):20-32.
227. Kreklau E.L., et al. A novel fluorometric oligonucleotide assay to measure O( 6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase. Nucleic Acids Res 2001, 29(12):2558-2566.
228. Goodwin K.D., et al. A high-throughput, high-resolution strategy for the study of site-selective DNA binding agents: analysis of a "highly twisted" benzimidazole-diamidine. J Am Chem Soc 2006, 128(24):7846-7854.
229. Tse W.C., Boger D.L. A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinity. Acc Chem Res 2004, 37(1):61-69.
230. Wilson D.M., Simeonov A. Small molecule inhibitors of DNA repair nuclease activities of APE1. Cell Mol Life Sci 2010, 67(21):3621-3631.
231. Bases R.E., Mendez F. Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy. Int J Radiat Oncol Biol Phys 1997, 37(5):1133-1137.
232. Bases R. Enhancement of x-ray damage in HeLa cells by exposure to lucanthone (Miracil D) following radiation. Cancer Res 1970, 30(7):2007-2011.
233. Hirschberg E., et al. Structure-activity studies on the mechanism of action of miracil D. Cancer Res 1968, 28(3):601-607.
234. Mendez F., Goldman J.D., Bases R.E. Abasic sites in DNA of HeLa cells induced by lucanthone. Cancer Invest 2002, 20(7-8):983-991.
235. Luo M., Kelley M.R. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res 2004, 24(4):2127-2134.
236. Seiple L.A., et al. Potent inhibition of human apurinic/apyrimidinic endonuclease 1 by arylstibonic acids. Mol Pharmacol 2008, 73(3):669-677.
237. Wolber G., et al. Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Drug Discov Today 2008, 13(1-2):23-29.
238. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997, 15:351-369.
239. Holmgren A. Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide. Structure 1995, 3(3):239-243.
240. Guo Y., et al. Redox regulation of the embryonic stem cell transcription factor oct-4 by thioredoxin. Stem Cells 2004, 22(3):259-264.
241. Whipple C., Korc M. Targeting angiogenesis in pancreatic cancer: rationale and pitfalls. Langenbecks Arch Surg 2008, 393(6):901-910.
242. Xie K., Wei D., Huang S. Transcriptional anti-angiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev 2006, 17(3):147-156.
243. Hiramoto M., et al. Nuclear targeted suppression of NF-kappa B activity by the novel quinone derivative E3330. J Immunol 1998, 160(2):810-819.
244. Shimizu N., et al. High-performance affinity beads for identifying drug receptors. Nat Biotechnol 2000, 18(8):877-881.
245. Su D.G., et al. Interactions of APE1 with a redox inhibitor: Evidence for an alternate conformation of the enzyme. Biochemistry 2010, December 8 [Epub ahead of print].
246. Kelley M.R., et al. Functional analysis of novel analogs of E3330 that block the redox signaling activity of the multifunctional AP endonuclease/redox signaling enzyme APE1/Ref-1. Antioxid Redox Signal 2010, 14(8):1387-1401.
247. Singh-Gupta V., et al. Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int J Cancer 2009, 124(7):1675-1684.
248. Raffoul J.J., et al. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res 2007, 67(5):2141-2149.
249. Yang S., et al. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther 2005, 4(12):1923-1935.
250. Yang Z., et al. Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol Cancer Ther 2008, 7(12):3751-3760.
251. Messina M., Kucuk O., Lampe J.W. An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels. J AOAC Int 2006, 89(4):1121-1134.
252. Pavese J.M., Farmer R.L., Bergan R.C. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 2010, 29(3):465-482.
253. Kovacic P., Somanathan R. Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety. Oxid Med Cell Longev 2010, 3(2):86-100.
254. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
255. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411(6835):366-374.
256. Damia G., D'Incalci M. Targeting DNA repair as a promising approach in cancer therapy. Eur J Cancer 2007, 43(12):1791-1801.
257. Karran P. Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 2001, 22(12):1931-1937.
258. Sanchez-Perez I. DNA repair inhibitors in cancer treatment. Clin Transl Oncol 2006, 8(9):642-646.
259. Kinsella T.J. Coordination of DNA mismatch repair and base excision repair processing of chemotherapy and radiation damage for targeting resistant cancers. Clin Cancer Res 2009, 15(6):1853-1859.
260. Yap T.A., et al. Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic. CA Cancer J Clin 2011, 61(1):31-49.
261. Canan Koch S.S., et al. Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure. J Med Chem 2002, 45(23):4961-4974.
262. Tikhe J.G., et al. Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly (ADP-ribose) polymerase. J Med Chem 2004, 47(22):5467-5481.
263. Miyashiro J., et al. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorg Med Chem Lett 2009, 19(15):4050-4054.
264. Reed A.M., Fishel M.L., Kelley M.R. Small-molecule inhibitors of proteins involved in base excision repair potentiate the anti-tumorigenic effect of existing chemotherapeutics and irradiation. Future Oncol 2009, 5(5):713-726.
265. O'Shaughnessy J., Osborne C., Pippen J. Final efficacy and safety results of a randomized phase II study of the PARP inhibitor iniparib (BSI-201) in combination with gemcitabine/carboplatin in metastatic triple negative breast cancer. Proceedings of the 35th European Society of Medical Oncology 2010, Abstract LBA11.
266. Krokan H.E., et al. Properties and functions of human uracil-DNA glycosylase from the UNG gene. Prog Nucleic Acid Res Mol Biol 2001, 68:365-386.
267. Neddermann P., et al. Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase. J Biol Chem 1996, 271(22):12767-12774.
268. Boorstein R.J., et al. Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. J Biol Chem 2001, 276(45):41991-41997.
269. Petronzelli F., et al. Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase. J Biol Chem 2000, 275(42):32422-32429.
270. Radicella J., et al. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of. Saccharomyces cerevisiae. Proc Natl Acad Sci, USA 1997, 94(15):8010-8015.
271. Slupska M.M., et al. Functional expression of hMYH, a human homolog of the Escherichia coli MutY protein. J Bacteriol 1999, 181(19):6210-6213.
272. Aspinwall R., et al. Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III. Proc Natl Acad Sci, USA 1997, 94(1):109-114.
273. Jaruga P., et al. Mouse NEIL1 protein is specific for excision of 2,6-diamino-4-hydroxy-5-formamidopyrimidine and 4,6-diamino-5-formamidopyrimidine from oxidatively damaged DNA. Biochemistry 2004, 43(50):15909-15914.